Abstract
In this chapter, as throughout this volume, we classify diseases according to where they originate, i.e., in which organ or physiological system. (see 4). All disease entities dealt with under Sects. 17.2–17.3 have in common, to variable degrees, impaired action of androgens or estrogens in their target organs. Gynecomastia represents an exception; this disorder will be discussed here more for reasons of clinical convenience rather than according to strictly nosological criteria.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Allera A, Herbst MA, Griffin JE, Wilson JD, Schweikert HU, McPhaul MJ (1995) Mutations of the androgen receptor coding sequence are infrequent in patients with isolated hypospadias. J Clin Endocrinol Metab 80:2697–2699
Arzneimittelkommission der Deutschen Ärzteschaft (2008) Eine Gynäkomastie durch Finasterid kann die Diagnose eines Mammakarzinoms beim Mann verzögern. Dtsch Ärztebl 105:C2038
Backe J (2002) Brustkrebs beim Mann. Dtsch Ärztebl 99: A1 168–1172
Braunstein GD (2007) Gynecomastia. New Engl J Med 357: 1229–1237
Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J, Korach KS, Simpson ER (1997) Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 337:91–95
Ellis JA, Scurrah KJ, Cobb JE, Zaloumis SG, Duncan AE, Harrap SB (2007) Baldness and the androgen receptor: The AR polyglycine repeat polymorphism does not confer susceptibility to androgenetic alopecia. Hum Genet 121: 451–457
Faustini-Fustini M, Rochira V, Carani C (1999) Oestrogen deficiency in men: Where are we today? Eur J Endocrinol 140: 111–129
Fentiman IS, Fourquet A, Hortobagyi GN (2006) Male breast cancer. Lancet 367:595–604
Gottlieb B, Beitel LK, Wu JH, Trifiro M (2004) The androgen receptor gene mutations database (ARDB): 2004 update. Hum Mutat 23:527–533
Griffin JE, McPhaul M, Russell DW, Wilson JD (1995) The androgen resistance syndromes: Steroid 5a-reductase 2 deficiency, testicular feminization, and related disorders. In: Scriver CE, Beaudet al, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, vol II, 7th edn. McGraw-Hill, New York, pp 2967–2998
Grumbach MM, Conte FA (1991) Disorders of sex differentiation. In: Wilson JD, Foster DW (eds) Textbook of endocrinology. W.B. Saunders, Philadelphia, PA, pp 853–951
Han TS, Goswami D, Trikudanathan S, Creighton SM, Conway GS (2008) Comparison of bone mineral density and body proportions between women with complete androgen insen-sitivity syndrome and women with gonadal dysgenesis. Eur J Endocrinol 159:179–185
Henley DV, Lipson N, Korach KS, Bloch C (2007) Prepubertal gynecomastia linked to lavender and tea tree oil. N Engl J Med 356:479–485
Hillmer AM, Flaquer A, Hanneken S, Eigelshoven S, Kortüm AK, Brockschmidt FF, GollaA, Metzen C, Thiele H, Kolberg S, Reinartz R, Betz RC, Ruzicka T, Hennies HC, Kruse R, Nöthen MM (2008) Genome-wide scan and fine-mapping linkage study of androgenetic alopecia reveals a locus on chromosome 3q26. Am J Hum Genet 82:737–743
Hughes IA, Houk C, Ahmed SF, Lee PA (2006) Consensus statement on management of intersex disorders. J Ped Urol 2:148–162
Hurt WG, Bodurtha JN, McCall JB, Ali MM (1989) Seminoma in pubertal patient with androgen insensitivity syndrome. Am J Obstet Gynecol 161:530–531
Imperato-McGinley J, Zhu YS (2002) Androgens and male physiology the syndrome of 5-alpha-reductase-2 deficiency. Mol Cell Endocrinol 198:51–59
Imperato-McGinley J, Peterson RE, Gautier T, Cooper G, Danner R, Arthur A, Morris PL, Sweeney WJ, Shackleton C (1982) Hormonal evaluation of a large kindred with complete androgen insensitivity: evidence for secondary 5a-reductase deficiency. J Clin Endocrinol Metab 54: 931–941
Kaufman KD (2004) Clinical use of 5a-reductase inhibitors. In: Nieschlag E, Behre HM (eds) Testosterone: action, deficiency, substitution, 3rd edn. Springer, Heidelberg, pp 571–596
Krause A, Sinnecker GH, Hiort O, Thamm B, Hoepffner W (2004) Applicability of the SHBG androgen sensitivity test in the differential diagnosis of 46,XY gonadal dysgenesis, true hermaphroditism, and androgen insensitivity syndrome. Exp Clin Endocrinol Diabetes 112:236–240
Kumanov P, Deepinder F, Robeva R, Tomova A, Li J, Agarwal A (2007) Relationship of adolescent gynecomastia with varic-ocele and somatometric parameters: a cross-sectional study in 6.200 healthy boys. J Adolesc Health 41:126–131
LaSpada AR, Roling DB, Harding AE, Warner CL, Spiegel R, Hausmanova-Petrusewicz I, Woon-Chee Y, Fischbeck KH (1992) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature Genetics 2:301–304
Lanfranco F, Zirilli L, Baldi M, Pignati E, Corneli G, Ghigo E, Aimaretti G, Carani C, Rochira V (2008) A novel mutation in the human aromatase gene: Insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment. Bone 43:628–635
Lobaccaro JM, Lumbroso S, Belon C, Galtier-Dereure F, Bringer J, Lesimple T, Namer M, Cutuli BF, Pujol H, Sultan C (1993) Androgen receptor gene mutation in male breast cancer. Hum Mol Genet 2:1799–1802
Maffei B, Murata Y, Rochira V, Tubert G, Aranda C, Vazquez M, Clyne CD, Davis S, Simpson ER, Carani C (2004) Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: Effects of testosterone, alendronate, and estradiol treatment. J Clin Endocrinol Metab 89:61–70
Mahoney CP (1990) Adolescent gynecomastia. Differential diagnosis and management. Ped Clin North Am 6: 1389–1404
Meikle AW (2004) The interrelationships between thyroid dysfunction and hypogonadism in men and boys. Thyroid 14(Suppl 1):S17–S25
Norwood OT (1975) Male pattern baldness: Classification and incidence. South Med J 68:1359–1365
Quigley CA (1998) The androgen receptor: Physiology and pathophysiology. In: Nieschlag E, Behre HM (eds) Testosterone: action, deficiency, substitution, 2nd edn. Springer, Heidelberg, pp 33–106
Randall VA (2004) Androgens and hair: The biological paradox. In: Nieschlag E, Behre HM (eds) Testosterone: action, deficiency, substitution, 3rd edn. Springer, Heidelberg, pp 207–231
Rodien P, Mebarki F, Mowszowicz I, Chaussain JL, Young J, Morel Y, Schaison G (1996) Different phenotypes in a family with androgen insensitivity caused by the same M780I point mutation in the androgen receptor gene. J Clin Endocrinol Metab 81:2994–2998
Rutgers JL, Scully RE (1991) The androgen insensitivity syndrome (testicular feminization): a clinicopathological study of 43 cases. Int J Gynecol Pathol 10:126–144
Shozu M, Sebastian S, Takayama K, Hsu WT, Schultz R, Neely K, Bryant M, Bulun SE (2003) Estrogen excess associated with novel gain-of-function mutations affecting the aro-matase gene. New Engl J Med 348:1855–1865
Sinclair R, Greenland KJ, Egmond S, Hoedemaker C, Chapman A, Zajac JD (2007) Men with Kennedy disease have a reduced risk of androgenetic alopecia. Br J Dermatol 157: 290–294
Sinnecker GHG, Hiort O, Dibbelt L, Albers N, Dörr HG, Hauß H, Heinrich U, Hemminghaus M, Hoepffner W, Holder M, Schnabel D, Kruse K (1996) Phenotypic classification of male pseudohermaphroditism due to steroid 5a-reductase 2 deficiency. Am J Med Genet 63:223–230
Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS (1994) Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. New Engl J Med 331:1056–1061
Wieacker P, Knoke I, Jakubiczka S (1998) Clinical and molecular aspects of androgen receptor defects. Exp Clin Endocrinol Diabetes 106:446–452
Wilson JD, Griffin JE, Russell DW (1993) Steroid 5a-reductase 2 deficiency. EndocrRev 14:577–593
Wooster R, Mangion J, Ecles R, Smith S, Dowsett M, Averill D, Barrett-Lee P, Easton DF, Ponder BAJ, Stratton MR (1992) A germ-line mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nat Genet 2:132–134
Yong EL, Ng SC, Roy AC, Yun G, Ratman SS (1994) Pregnancy after hormonal correction of severe spermatogenic defect due to a mutation in androgen receptor gene. Lancet 344:826–827
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Wieacker, P.F., Behre, H.M., Nieschlag, E. (2010). Disorders of Androgen Target Organs. In: Nieschlag, E., Behre, H.M., Nieschlag, S. (eds) Andrology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-78355-8_17
Download citation
DOI: https://doi.org/10.1007/978-3-540-78355-8_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-78354-1
Online ISBN: 978-3-540-78355-8
eBook Packages: MedicineMedicine (R0)